We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
313 result(s) found, displaying 81 to 90
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Progesterone
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Prescription medicine registrationActive ingredients: progesterone.
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia
-
Cancellation by sponsorRequested by Orion Laboratories Pty Ltd T/A Perrigo Australia